Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.
African Americans are twice as likely to be diagnosed with multiple myeloma as white people, but lag in treatment gains.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
Warring Khushwinder, 59, an engineer and a member of the Sikh faith, lives in Orangevale, California. He had multiple myeloma.
Certain types of cancer treatment can lead to inadequate immune response.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
A study from the Leukemia & Lymphoma Society finds that antibody production varies widely across blood cancer types.
The monoclonal antibody reduces the risk of disease progression or death by 45%.
More than 70% of people treated with Abecma, a customized immunotherapy, experienced complete or partial remission.
Nearly a quarter of patients treated with the peptide-drug conjugate experienced partial remission.
Study finds that ide-cel produces remissions in almost 75% of patients with multiple myeloma who had relapsed after previous treatments.
After approval of the latest cellular therapy for non-Hodgkin lymphoma, the big challenge is how to extend it to common solid tumors.
Xpovio (selinexor) was approved for adults with multiple myeloma who have received at least one prior therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.